Datadog CTO Le-Quoc sells 53,912 shares under plan
The sale entries were tied to a Rule 10b5-1 plan dated June 13, 2025, and the reported transactions also include option exercise and share conversions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Datadog, Inc. Chief Technology Officer Alexis Le-Quoc reported exercising options to acquire 10,688 shares at $10.74 per share on October 7, 2026; 120,562 options were reported afterward. The transactions also list a Class B-to-Class A conversion of 53,912 shares, with Class A acquisition entries. Le-Quoc sold 53,912 Class A shares in nine sales under a Rule 10b5-1 plan dated June 13, 2025, at weighted-average prices from $271.3954 to $280.4283 per share. The Alexis Le-Quoc Revocable Trust is listed with 6,146,835 Class B shares and 169 Class A shares.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F13 | 10,688 | $0.00 | $0.00 |
| Exercise | Class B Common Stock F1 | 10,688 | $10.74 | $115K |
| Conversion | Class B Common Stock F1 | 53,912 | $0.00 | $0.00 |
| Conversion | Class A Common Stock F1 | 43,224 | $0.00 | $0.00 |
| Conversion | Class A Common Stock F1 | 10,688 | $0.00 | $0.00 |
| Sale | Class A Common Stock F2, F3 | 18,609 | $271.3954 | $5.05M |
| Sale | Class A Common Stock F2, F4 | 5,338 | $272.2528 | $1.45M |
| Sale | Class A Common Stock F2, F5 | 2,789 | $273.2656 | $762K |
| Sale | Class A Common Stock F2, F6 | 13,036 | $274.5108 | $3.58M |
| Sale | Class A Common Stock F2, F7 | 8,268 | $275.2553 | $2.28M |
| Sale | Class A Common Stock F2, F8 | 2,272 | $276.2291 | $628K |
| Sale | Class A Common Stock F2, F9 | 1,700 | $277.3618 | $472K |
| Sale | Class A Common Stock F2, F10 | 1,300 | $278.8838 | $363K |
| Sale | Class A Common Stock F2, F11 | 600 | $280.4283 | $168K |
| holding | Class B Common Stock F1, F12 | -- | -- | -- |
| holding | Class A Common Stock F12 | -- | -- | -- |
Footnotes (13)
- F1. Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.
- F2. Shares sold pursuant to a 10b5-1 plan dated June 13, 2025.
- F3. Price reported is a weighted-average sales price. The shares were sold at prices ranging from $270.85 to $271.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F4. Price reported is a weighted-average sales price. The shares were sold at prices ranging from $271.85 to $272.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F5. Price reported is a weighted-average sales price. The shares were sold at prices ranging from $272.85 to $273.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F6. Price reported is a weighted-average sales price. The shares were sold at prices ranging from $273.85 to $274.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F7. Price reported is a weighted-average sales price. The shares were sold at prices ranging from $274.85 to $275.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F8. Price reported is a weighted-average sales price. The shares were sold at prices ranging from $275.86 to $276.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F9. Price reported is a weighted-average sales price. The shares were sold at prices ranging from $276.92 to $277.91. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F10. Price reported is a weighted-average sales price. The shares were sold at prices ranging from $278.70 to $279.60. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F11. Price reported is a weighted-average sales price. The shares were sold at prices ranging from $280.05 to $280.60. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F12. Shares are held by the Alexis Le-Quoc Revocable Trust.
- F13. Option is fully vested and exercisable.
Key Figures
Key Terms
Rule 10b5-1 plan regulatory
weighted-average sales price financial
fully vested and exercisable financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many options did Datadog's CTO exercise, and at what price?
AI-generated analysis. How Rhea-AI works. Not financial advice.